| Company Name: |
JinOu Biomedical (Nanjing) Co., Ltd.
|
| Tel: |
13000000000 |
| Email: |
jinoupharma@163.com |
| Products Intro: |
Product Name:1-[4-[2,2-di(phenyl)ethylamino]-3-(morpholine-4-carbonyl)phenyl]sulfonylpiperidin-4-yl]-(4-methylpiperazin-1-yl)methanone
Purity:99% HPLC Package:100G;1KG;100KG
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:NVP-SAA164
CAS:312722-60-4
Package:100mg;500mg
|
|
| | NVP-SAA 164 Basic information |
| Product Name: | NVP-SAA 164 | | Synonyms: | NVP-SAA 164;[1-[4-[2,2-DI(PHENYL)ETHYLAMINO]-3-(MORPHOLINE-4-CARBONYL)PHENYL]SULFONYLPIPERIDIN-4-YL]-(4-METHYLPIPERAZIN-1-YL)METHANONE;SAA 164;SAA164;SAA-164;Methanone, [2-[(2,2-diphenylethyl)amino]-5-[[4-[(4-methyl-1-piperazinyl)carbonyl]-1-piperidinyl]sulfonyl]phenyl]-4-morpholinyl- | | CAS: | 312722-60-4 | | MF: | C36H45N5O5S | | MW: | 659.84 | | EINECS: | | | Product Categories: | | | Mol File: | 312722-60-4.mol |  |
| | NVP-SAA 164 Chemical Properties |
| Boiling point | 871.0±75.0 °C(Predicted) | | density | 1.275±0.06 g/cm3(Predicted) | | pka | 6.80±0.10(Predicted) |
| | NVP-SAA 164 Usage And Synthesis |
| Description | NVP-SAA164 is a nonpeptide bradykinin B1 receptor antagonist. | | Uses | NVP-SAA164 is an orally active nonpeptide kinin B1 receptor antagonist. NVP-SAA164 reverses CFA (Complete Freund's adjuvant) (HY-153808)-induced mechanical hyperalgesia and desArg10KD-induced hyperalgesia in hB1-KI mice, and is inactive in a model of inflammatory pain in wild-type mice[1]. | | References | [1] Fox A, et al. Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor. Br J Pharmacol. 2005 Apr;144(7):889-99. DOI:10.1038/sj.bjp.0706139 |
| | NVP-SAA 164 Preparation Products And Raw materials |
|